Agilent Technologies officially opened a new life sciences manufacturing facility in Singapore, designed to produce liquid-handling and laboratory robotic instruments.  The instruments to be manufactured here will be used by pharmaceutical companies for mass commerical production of drugs.  "Singapore is our natural choice for our life sciences manufacturing site as the island-state is home to the world's top pharmaceutical and biotechnology companies and is well-positioned to be the leading global manufacturing site for innovative medicines," said Gooi Soon Chai, president of Agilent Technologies Singapore.